The article presents a case study of a 66-year-old woman who experienced seizure and hypoglycaemia that led to encephalopathy due to overdosage of insulin, insulin glargine and insulin aspart.doi:10.1007/s40278-015-1954-2NoneSpringer International PublishingReactions Weekly...
8.8 Obesity In controlled clinical trials, subgroup analyses based on BMI did not show differences in safety and efficacy between BASAGLAR and another insulin glargine product, 100 units/mL. 10 OVERDOSAGE Excess insulin administration relative to food intake, energy expenditure, or both may lead ...
Generic name:insulin glargine[IN-su-lin-GLAR-gine] Brand names:Lantus,Lantus SoloStar Drug class:Insulin Medically reviewed byKaci Durbin, MD. Last updated on Aug 21, 2023. Uses Warnings Before taking Dosage Side effects Interactions FAQ
Dosage of insulin glargine is expressed in units.Dosage of insulin glargine/lixisenatide has been expressed in terms of the insulin glargine component; however, each mL of insulin glargine/lixisenatide contains 100 units of insulin glargine and 33 mcg of lixisenatide....
in lispro overdose. Insulin glargine/insulin lispro overdose.Insulin glargine/insulin lispro overdose.The article cites a case report on the development of hypoglycaemia due to overdosage of insulin.EBSCO_AspReactions Weekly
Insulin therapy requires careful monitoring of blood glucose levels to adjust the dosage and prevent hypoglycemia or hyperglycemia. Overall, insulin is a vital hormone that plays a crucial role in maintaining glucose homeostasis and is essential for the management of diabetes. View more+ ...
Tresiba® U-100 is a basal insulin that has demonstrated significantly lower rates of severe hypoglycemia vs insulin glargine U-1001,3-5 Rate of severe hypoglycemia events1 Tresiba® U-100 3.70 events per 100 patient-yearsc 4.9% of patients experienced ≥1...
Recently, the clinical proof of concept for the first ultra-long oral insulin was reported, showing efficacy and safety similar to subcutaneously administered insulin glargine. Here, we report the molecular engineering as well as biological and pharmacological properties of these insulin analogues. Molecu...
cThe in-use insulin glargine U-100 vial must be discarded after 4 weeks and the in-use insulin detemir pen and vial must be discarded after 6 weeks.2,3 Indications and Usage for Tresiba®(insulin degludec) injection 100 U/mL, 200 U/mL ...
Do not transfer insulin degludec from the prefilled pen to a syringe; the markings on the insulin syringe will not measure the dose correctly and can result in overdosage and severe hypoglycemia. Changes in insulin, insulin strength, manufacturer, type, or method of administration may affect glyc...